Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M630Revenue $M230Net Margin (%)47.0Altman Z-Score25.3
Enterprise Value $M433EPS $2.4Operating Margin %56.6Piotroski F-Score7
P/E(ttm)8.6Beneish M-Score52.3Pre-tax Margin (%)56.6Higher ROA y-yY
Price/Book2.910-y EBITDA Growth Rate %--Quick Ratio19.4Cash flow > EarningsY
Price/Sales3.45-y EBITDA Growth Rate %--Current Ratio19.4Lower Leverage y-yY
Price/Free Cash Flow8.2y-y EBITDA Growth Rate %--ROA % (ttm)51.3Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)57.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M28.8ROIC % (ttm)626Gross Margin Increase y-yN

Gurus Latest Trades with NLNK

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NLNKJoel Greenblatt 2015-09-30 Sold Out -0.46%$35.26 - $55.01
($48.76)
$ 20.99-57%Sold Out0
NLNKFirst Eagle Investment 2015-09-30 Add0.01%$35.26 - $55.01
($48.76)
$ 20.99-57%Add 9.13%1,876,600
NLNKJoel Greenblatt 2015-06-30 Add0.15%$36.55 - $56.87
($47.33)
$ 20.99-56%Add 48.51%1,244,856
NLNKFirst Eagle Investment 2015-06-30 Add0.03%$36.55 - $56.87
($47.33)
$ 20.99-56%Add 20.19%1,719,600
NLNKJoel Greenblatt 2015-03-31 Buy 0.35%$31.95 - $56.4
($43.06)
$ 20.99-51%New holding838,221
NLNKFirst Eagle Investment 2015-03-31 Add$31.95 - $56.4
($43.06)
$ 20.99-51%Add 1.73%1,430,700
NLNKFirst Eagle Investment 2014-03-31 Add0.02%$21.38 - $50.4
($33.68)
$ 20.99-38%Add 28.35%1,161,805
NLNKFirst Eagle Investment 2013-09-30 Add0.01%$15.78 - $20.08
($17.83)
$ 20.9918%Add 21.32%778,354
NLNKFirst Eagle Investment 2013-06-30 Add0.02%$11.27 - $22.56
($15.73)
$ 20.9933%Add 95.04%641,554
NLNKFirst Eagle Investment 2013-03-31 Buy 0.01%$11.4 - $12.7
($12.08)
$ 20.9974%New holding328,939
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NLNK is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


NLNK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Ramsey William J.Quality Assurance Officer 2015-02-17Sell2,500$40-47.85view
Wiley BrianVP of Business Development 2015-02-17Sell10,000$40.07-47.94view
Link Charles J. Jr.Chairman of the Board and CEO 2015-02-05Sell20,000$32.41-35.64view
Ramsey William J.Quality Assurance Officer 2015-01-23Sell2,500$40-47.85view
Link Charles J. Jr.Chairman of the Board and CEO 2015-01-07Sell20,000$37.99-45.09view
Wiley BrianVP of Business Development 2015-01-02Sell20,000$40.33-48.28view
Link Charles J. Jr.Chairman of the Board and CEO 2014-12-04Sell20,000$37.84-44.87view
HENNEMAN JOHN B IIIEVP, CFO 2014-11-25Buy5,000$34.35-39.27view
Link Charles J. Jr.Chairman of the Board and CEO 2014-11-10Sell20,000$32.94-36.67view
LINK GORDON H JRCFO 2014-10-24Sell2,500$40.39-48.35view

Quarterly/Annual Reports about NLNK:

News about NLNK:

Articles On GuruFocus.com
First Eagle Investment Adds to Stake in NewLink Genetics Feb 03 2016 
These Companies Show High Profit and Low Debt Jun 17 2015 
When A Stock Doubles, Don’t Trim It Automatically May 27 2015 
Greenblatt's Top Buys During First Quarter May 22 2015 
NewLink Genetics Corporation Offers a Risky Way to Generate Income Sep 11 2013 
Weekly CEO Sells Highlight: Universal Insurance Holdings Inc, Avanir Pharmaceuticals Inc, Bel Fuse I Jun 30 2012 

More From Other Websites
Trade Boost From Trans-Pacific Partnership? Feb 06 2016
The Zacks Analyst Blog Highlights: Biogen, Gilead, AbbVie, Intrexon and NewLink Feb 04 2016
First Eagle Investment Adds to Stake in NewLink Genetics Feb 03 2016
NewLink Genetics says working on Zika vaccine Feb 02 2016
NewLink Genetics Corporation Announces Project to Develop New Treatment Options for the Zika Virus Feb 02 2016
NEWLINK GENETICS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jan 22 2016
NewLink Genetics Presents Phase 1b Data of Indoximod in Combination With Gemcitabine/Nab-Paclitaxel... Jan 22 2016
NewLink Genetics Presents Phase 1b Data of Indoximod in Combination With Gemcitabine/Nab-Paclitaxel... Jan 22 2016
NewLink Genetics Corporation to Present Phase 1b Data on Indoximod in Combination Therapy in... Jan 19 2016
NewLink Genetics Corporation to Present Phase 1b Data on Indoximod in Combination Therapy in... Jan 19 2016
NewLink Genetics Corporation Appoints Brian Wiley as Chief Commercial Officer Jan 08 2016
NewLink Genetics Corporation Appoints Brian Wiley as Chief Commercial Officer Jan 08 2016
NEWLINK GENETICS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in... Jan 07 2016
How NewLink Genetics Corp (NLNK) Stock Stands Out in a Strong Industry Dec 28 2015
NewLink Genetics Corp. breached its 50 day moving average in a Bullish Manner : December 22, 2015 Dec 22 2015
NEWLINK GENETICS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 15 2015
NewLink Genetics Corporation Completes Enrollment of Phase 3 PILLAR Trial Evaluating Algenpantucel-L... Dec 15 2015
NewLink Genetics Corporation Completes Enrollment of Phase 3 PILLAR Trial Evaluating Algenpantucel-L... Dec 15 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK